Anterix Inc has a consensus price target of $59.67, established from looking at the 6 latest analyst ratings. The last 3 analyst ratings were released from B. Riley Securities, Morgan Stanley, and Morgan Stanley on February 16, 2024, August 1, 2023, and February 24, 2023. With an average price target of $52.67 between B. Riley Securities, Morgan Stanley, and Morgan Stanley, there's an implied 64.79% upside for Anterix Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
02/16/2024 | ATEX | Buy Now | Anterix | $31.96 | 134.67% | B. Riley Securities | Mike Crawford | → $75 | Maintains | Buy | Get Alert |
08/01/2023 | ATEX | Buy Now | Anterix | $31.96 | 28.29% | Morgan Stanley | Nigel Dally | $42 → $41 | Maintains | Equal-Weight | Get Alert |
02/24/2023 | ATEX | Buy Now | Anterix | $31.96 | 31.41% | Morgan Stanley | Nigel Dally | $63 → $42 | Maintains | Equal-Weight | Get Alert |
02/10/2022 | ATEX | Buy Now | Anterix | $31.96 | 97.12% | Morgan Stanley | Simon Flannery | $65 → $63 | Maintains | Equal-Weight | Get Alert |
08/04/2021 | ATEX | Buy Now | Anterix | $31.96 | 103.38% | Morgan Stanley | Simon Flannery | — | Maintains | Equal-Weight | Get Alert |
06/09/2021 | ATEX | Buy Now | Anterix | $31.96 | 59.57% | Morgan Stanley | Simon Flannery | — | Maintains | Equal-Weight | Get Alert |
The latest price target for Anterix (NASDAQ: ATEX) was reported by B. Riley Securities on February 16, 2024. The analyst firm set a price target for $75.00 expecting ATEX to rise to within 12 months (a possible 134.67% upside). 2 analyst firms have reported ratings in the last year.
The latest analyst rating for Anterix (NASDAQ: ATEX) was provided by B. Riley Securities, and Anterix maintained their buy rating.
There is no last upgrade for Anterix.
There is no last downgrade for Anterix.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Anterix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Anterix was filed on February 16, 2024 so you should expect the next rating to be made available sometime around February 16, 2025.
While ratings are subjective and will change, the latest Anterix (ATEX) rating was a maintained with a price target of $0.00 to $75.00. The current price Anterix (ATEX) is trading at is $31.96, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.